Translating research into treatments

TY - JOUR

T1 - Translating research into treatments

AU - Noseworthy, John H.

AU - Gross, Robert A.

AU - Engel, Andrew G.

AU - Johnston, Karen C.

AU - Knopman, David S.

AU - Mink, Jonathan W.

AU - Ransohoff, Richard M.

AU - Uitti, Ryan J.

N1 - Funding Information: Richard M. Ransohoff, MD , conducts research supported by the NIH, the National MS Society, the Dana Foundation, and the Nancy Davis Center without Walls. Dr. Ransohoff has received fees for pre-clinical consulting from Amgen, Astra-Zeneca, Biogen-Idec, Boehringer Ingelheim, Merck, Merck-Serono, Merrimack, Millennium, Momenta, Novartis, Novimmune, Pharmacopeia, Schering-Plough, Vertex, and Xanthus. Dr. Ransohoff serves on the Immunology/Inflammation subgroup of Vertex Pharmaceuticals Incorporated's Scientific Advisory Board, the ChemoCentryx Scientific Advisory Board, and a Safety Evaluation Committee for Merck. Funding Information: Jonathan W. Mink, MD, PhD , has received funding from the NIH and is on the medical advisory board of the Batten Disease Support and Research Association, the Scientific Advisory Board of Tourette Syndrome Association, and the Medical Advisory Board of the Pediatric Neurotransmitter Disease Association. Funding Information: Robert A. Gross, MD, PhD, FAAN , has received research funding from the Department of the Army and UCBPharma. He is supported for educational endeavors from the University of Rochester Medical Center's Clinical and Translational Science Award from the NIH. Dr. Gross has conducted clinical trials over the past 5 years funded by GlaxoSmithKline, UCB, Ortho-McNeil, Pfizer, and Marinus. Dr. Gross has served on the speakers' bureaus for Abbott, UCB, Ortho-McNeil, and GlaxoSmithKline and has received consultant fees from GlaxoSmithKline and Harris Interactive. Funding Information: Ryan J. Uitti, MD, FAAN , has received funding from the NIH, Pacific Alzheimer Research Foundation, and Advanced Neuromodulation Systems. Funding Information: Andrew G. Engel, MD, FAAN , receives research funding from the NIH and from the Muscular Dystrophy Association. Funding Information: Karen C. Johnston, MD, MSc , has received research funding from the NIH (three grants); consults for Diffusion Pharmaceutical, Inc., and Remedy Pharmaceutical; is on the Advisory Board for RemedyPharmaceutical; receives royalties from Up to Date; and receives speaker honoraria from BI.

PY - 2008/7/22

Y1 - 2008/7/22

UR - http://www.scopus.com/inward/record.url?scp=50549095773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50549095773&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000314830.63429.a1

DO - 10.1212/01.wnl.0000314830.63429.a1

M3 - Editorial

C2 - 18525031

AN - SCOPUS:50549095773

VL - 71

SP - 232

EP - 233

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4

ER -